Alger Small Cap Focus Fund Q4 2025 Portfolio Update [Seeking Alpha]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Exact Sciences Corporation, Guardant Health, Inc., and Natera, Inc. were among the top contributors to performance. Nebius Group, uniQure N.V., and Stevanato Group were among the top detractors from performance. Chainarong Prasertthai/iStock via Getty Images The following segment was excerpted from the Alger Small Cap Focus Fund Q4 2025 Commentary. Class A shares of the Alger Small Cap Focus Fund outperformed the Russell 2000 Growth Index during the fourth This article was written by Quick Insights Abbott's definitive agreement to acquire EXAS for $21 billion in cash delivered a meaningful premium, driving EXAS shares higher and contributing positively to fund performance. Both GH and NTRA posted strong Q3 results and raised full-year 2025 revenue guidance, with NTRA also exceeding margin expectations due to higher test volumes and favorable reimbursement. NBIS faced AI sector volatility and financing concerns, QURE encountered regulatory uncertainty for AMT-130, an
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026Business Wire
- Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Guardant Health: Look For Explosive Revenue Growth Ahead [Seeking Alpha]Seeking Alpha
- Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 1/22/26 - Form 4
- 1/22/26 - Form 4
- 1/22/26 - Form 5
- GH's page on the SEC website